Medasys Prometra implantable drug pump wins FDA PMA approval
The US Food and Drug Administration (FDA) has granted a premarket approval (PMA) to Medasys' Prometra programmable implantable drug pump.
Prometra is a non-peristaltic programmable implantable pump which delivers Infumorph (preservative-free morphine sulfate sterile solution) intraspinally to manage pain.
The Prometra also uses a patented valve gated precision dosing system to achieve extremely high accuracy, minimize dose variations due to temperature, pressure, flow rate, or reservoir fill levels.
Medasys said a clinical trial also showed 97% clinical accuracy in the delivery of the physician-programmed dose.
Related Insight
Suppliers Directory
Specialty Devices
Anesthesia & Respiratory Devices
Cardiovascular Devices
Dental Devices
Diabetes Care Devices
Drug Delivery Devices
Orthopedic Devices
Diagnostics In Vitro Diagnostics Diagnostic Imaging Endoscopy Devices
Patient Care Patient Monitoring Surgical & Supplies Wound Care Management
Technology Automation Healthcare IT Packaging
Contract Services
Certification
Diagnostics In Vitro Diagnostics Diagnostic Imaging Endoscopy Devices
Patient Care Patient Monitoring Surgical & Supplies Wound Care Management
Technology Automation Healthcare IT Packaging
Contract Services
Certification
Drug Delivery Devices Intelligence
Buy the latest industry research online today!
External Defibrillators - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016
GlobalData’s new report, “External Defibrillators - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016” provides key data, information and analysis on the global external defibrillators market. The report provides market landscape, competitive landscape and market trends information the external defibrillators market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. Buy online from $3500
GlobalData’s new report, “External Defibrillators - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016” provides key data, information and analysis on the global external defibrillators market. The report provides market landscape, competitive landscape and market trends information the external defibrillators market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. Buy online from $3500
Comments may be moderated for spam, obscenities or defamation.